Google introduced the Pixel Watch 5 today, but the most notable announcements are two new health features coming this fall designed to detect conditions people often don’t realize they have.
The features focus on detecting elevated blood pressure trends and signs of insulin resistance—both important early indicators of cardiometabolic risk and potential precursors to diabetes. These problems are frequently silent; you can have rising blood pressure or worsening insulin sensitivity long before you notice any symptoms.
Worldwide, hundreds of millions of adults experience blood pressure changes without realizing it, and a large portion of adults in the United States may have some degree of insulin resistance without knowing. Early detection can prompt simple follow-up actions, like measuring blood pressure with a cuff or getting routine lab tests, which may lead to earlier care and better outcomes.
Catching blood pressure changes before they add up
Google’s blood pressure feature runs passively, using the watch’s optical sensor to analyze pulse wave patterns over time, including during sleep. Rather than issuing frequent alerts for normal day-to-day fluctuations, the system provides a monthly summary delivered on the first day of each month. That summary highlights whether your measurements are trending upward, stable, or lower, giving users a clear, simple signal about patterns instead of isolated numbers.
This approach is intentionally conservative: no smartwatch currently measures blood pressure directly the way a cuff does. Even dedicated devices that estimate blood pressure typically require periodic recalibration with a cuff to maintain accuracy. Google avoids presenting precise systolic and diastolic readings and focuses on trend detection as an early warning. If the watch indicates an elevated trend, it encourages confirming the result with a validated at-home monitor and consulting a healthcare professional.
Google reports that its blood pressure model was evaluated against 24-hour ambulatory blood pressure monitoring—the clinical standard used by doctors—yet the company recommends treating the watch’s output as a wellness signal rather than a definitive diagnosis.
A window into how your body handles energy
Insulin resistance occurs when cells become less responsive to insulin, forcing the body to produce more insulin to manage blood sugar. Over time, this can lead to type 2 diabetes. Traditionally, detecting insulin resistance requires fasting blood tests administered in a clinical setting, which can delay awareness and intervention.
The Pixel Watch 5 estimates trends related to insulin sensitivity by analyzing a month of heart rate, sleep, and activity data. Google says the model was validated against standard laboratory blood tests. Like the blood pressure feature, this tool is intended to prompt follow-up testing and conversation with a healthcare provider rather than replace diagnostic blood work.
Both features are scheduled to roll out to Pixel Watch 5 users this September. Google also plans to bring the same capabilities to existing Pixel Watch models and to compatible Fitbit devices, so current owners will not need to upgrade to access them. The wider industry trend toward passive, continuous health monitoring suggests these kinds of wellness insights will become more common across wearable platforms.
As for the hardware, the Pixel Watch 5 starts at $399, a modest increase from the previous model. It is available for pre-order now, with expected retail availability in late August. For anyone concerned about heart health or metabolic risk, the new software tools aim to make it easier to spot early signals and take timely action with clinical confirmation.